This report was recently updated on April 16 2024 with the latest and most recent
market numbers
Global Clinical Trial Supplies Market Size, Trends & Analysis - Forecasts to 2027 By Clinical Phase (Phase I, Phase II, Phase III, Others), By Service (Manufacturing, Storage & Distribution, Supply Chain Management), By Therapeutic Use (Oncology, Diabetes), By End Use (Pharmaceuticals, CROs), By Region (North America, Asia Pacific, Central, and South America, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis
The global clinical trial supplies market is projected to grow from USD 2.1 Billion in 2022 to USD 2.9 Billion in 2027 at a CAGR value of 8.5% from 2022 to 2027.
The market is mainly driven by the growing investment in the development of novel pharmaceuticals. The growing number of clinical trials across the globe, stringent regulatory restrictions, and guidelines for drug approval that varies region by region, growing incidence of infections, and rising investment in cancer research are expected to propel the clinical trial supplies market forward.
Due to the growing complexity and cost of clinical studies, medication developers and manufacturers have been forced to outsource their clinical trial supplies and have them delivered to the investigator's location. The demand for clinical trial materials and equipment has also increased as a result of technological advancements in the clinical trial supply chain system, strategic growth among service providers, and an uptick in the number of intellectual property patent expirations. Additionally, the quick growth of developing nations offers market players a wealth of additional leads.
Other factors driving the growth of the clinical trial supplies market include increased demand in clinical trials around the world, rising disease incidences, government funding for R&D, and the development of new treatments such as personalized medicine, all of which are expected to propel the clinical trial supplies market forward in the future.
In order to address the problem and stay up-to-date with the latest trends, new products have been brought to market by the presence of COVID-19. The technology that has served as the foundation for virtual trials is gradually gaining ground and is expected to experience substantial growth in the coming years. Many institutions have terminated or rescheduled at least one clinical study due to the pandemic's repercussions, which include social isolation and travel restrictions. Virtual trials are therefore rapidly being accepted in order to avoid such situations, enabling the deployment of novel approaches to trials and assuring a better patient experience.
The phase 1 segment is expected to be the fastest-growing segment in the market from 2022 to 2027. Due to increased R&D activity in the biotechnology field and a vast number of phase I trials for COVID-19 treatment and prevention, the phase I clinical trials market is predicted to grow at the quickest rate.
The market was dominated by the phase III category. This is owing to the increased demand for supply chain management in this phase, as well as the increasing complexity of clinical supplies and the increased number of patients. Clinical trials in Phase III are more difficult to conduct than those in earlier phases. The complexity level is the highest during this period, considering the fact that the quantity of drugs utilized is quite low. The sample size and research design need precise dosing at an ideal level, which explains why this phase has the greatest failure rate. Failure has huge capital and personnel expenses, and the majority of failures are due to disregard for safety and performance standards. The demand for effective supply chains and logistics is anticipated to rise in such an event, which would be favorable for higher growth.
The supply chain management segment is expected to be the largest segment in the market from 2022 to 2027. The need for supply chain management systems from life science companies and contract research organisations (CROs) is projected to rise as clinical trials become more widespread and there are more clinical locations.
The Oncology segment is expected to be the largest segment in the market from 2022 to 2027. This is due to the presence of a large cancer medication R&D pipeline. The majority of oncology treatments need to be distributed in a temperature-sensitive manner, which is predicted to increase demand for cold chain distribution.
The pharmaceuticals segment is expected to be the fastest-growing segment in the market from 2022 to 2027. This growth can be ascribed to these companies' increased R&D efforts.
The pharmaceuticals industry has become increasingly prominent in the market as a result of increased investments in research & development.
North America will have a dominant share in the clinical trial supplies market from 2022 to 2027. The expansion of the North American market is being fueled by an increase in the number of medical institutions conducting clinical trials in the area, favorable government regulations, and the availability of affordable supplies.
The Asia Pacific is predicted to be one of the world's fastest-growing regions. Clinical research's significant expansion is predicted to boost the market growth in the region, contributing to market growth. The primary factors promoting the rise of clinical research in Asia Pacific nations are the low cost per patient and the availability of a large patient population that is simple to enlist.
Catalent, Inc. (US), Almac Group (UK), Biocair (US), SIRO Clinpharm Private Limited (India), Sharp (Japan), Parexel International Corporation (US), Alium Medical Limited (UK), Ancillare, LP. (US) and Thermo Fisher Scientific Inc. (US) among others, are some of the key players in the clinical trial supplies market.
Please note: This is not an exhaustive list of companies profiled in the report.
Chapter 1 Research Methodology
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GME’s Internal Database
1.3.3 Primary Research
1.3.4 Secondary Sources & Third-Party Perspectives
1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website
1.3.4.2 Secondary Data Sources: World Health Organization, Laboratory Corporation of America Holdings, IQVIA, Syneos Health
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Therapeutic Use & Data Visualization
1.6 Data Validation & Publishing
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Top-Down Approach
1.7.1.2 Bottom-Up Approach
1.8 Market Segmentation & Scope
1.9 Market Definition
Chapter 2 Executive Summary
2.1. Global Market Outlook
2.2 Clinical Phase Outlook
2.3 Service Outlook
2.4 Therapeutic Use Outlook
2.5 End-User Outlook
2.6 Regional Outlook
Chapter 3 Global Clinical Trial Supplies Market Trend Analysis
3.1. Market Introduction
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on the Clinical Trial Supplies Market
3.4 Metric Data on Healthcare Industry
3.5 Market Dynamic
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.5.4 Industry Opportunities
3.6 Porter’s Five Analysis
3.6.1 Supplier Power
3.6.2 Buyer Power
3.6.3 Substitution Threat
3.6.4 Threat from New Entrant
3.7 Market Entry Strategies
Chapter 4 Clinical Trial Supplies Market: Clinical Phase Trend Analysis
4.1 Clinical Phase: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
4.2 Phase 1
4.2.1 Market Estimates & Forecast Analysis of Phase 1 Segment, By Region, 2019-2027 (USD Billion)
4.3 Phase 2
4.3.1 Market Estimates & Forecast Analysis of Phase 2 Markets Segment, By Region, 2019-2027 (USD Billion)
4.4 Phase 3
4.4.1 Market Estimates & Forecast Analysis of Phase 3 Markets Segment, By Region, 2019-2027 (USD Billion)
4.5 Other phases
4.5.1 Market Estimates & Forecast Analysis of Other phases Markets Segment, By Region, 2019-2027 (USD Billion)
Chapter 5 Clinical Trial Supplies Market: Services Trend Analysis
5.1 Services: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
5.2 Manufacturing
5.2.1 Market Estimates & Forecast Analysis of Manufacturing Segment, By Region, 2019-2027 (USD Billion)
5.3 Storage & Distribution
5.3.1 Market Estimates & Forecast Analysis of Storage & Distribution Segment, By Region, 2019-2027 (USD Billion)
5.4 Supply Chain Management
5.4.1 Market Estimates & Forecast Analysis of Supply Chain Management Segment, By Region, 2019-2027 (USD Billion)
Chapter 6 Clinical Trial Supplies Market: Therapeutic Use Trend Analysis
6.1 Therapeutic Use: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
6.2 Oncology
6.2.1 Market Estimates & Forecast Analysis of Oncology Segment, By Region, 2019-2027 (USD Billion)
6.3 Diabetes
6.3.1 Market Estimates & Forecast Analysis of Governance, Diabetes Segment, By Region, 2019-2027 (USD Billion)
Chapter 7 Clinical Trial Supplies Market: End-User Trend Analysis
7.1 End-User: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027
7.2 CROs
7.2.1 Market Estimates & Forecast Analysis of CROS Segment, By Region, 2019-2027 (USD Billion)
7.3 Pharmaceuticals
7.3.1 Market Estimates & Forecast Analysis of Pharmaceuticals Segment, By Region, 2019-2027 (USD Billion)
Chapter 9 Clinical Trial Supplies Market, By Region
8.1 Regional Outlook
8.2 North America
8.2.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.2.2 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.2.3 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.2.4 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.2.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.2.6 U.S.
8.2.6.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.2.6.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.2.6.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.2.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.2.7 Canada
8.2.7.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.2.7.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.2.7.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.2.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.2.8 Mexico
8.2.8.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027 (USD Billion)
8.2.8.2 Market Estimates & Forecast Analysis, By Services, 2019-2027 (USD Billion)
8.2.8.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027 (USD Billion)
8.2.8.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3 Europe
8.3.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.3.2 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.3 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.4 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.6 Germany
8.3.6.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.6.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.6.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.7 UK
8.3.7.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.7.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.7.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.8 France
8.3.8.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.8.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.8.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.8.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.9 Netherlands
8.3.9.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.9.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.9.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.10 Italy
8.3.10.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.10.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.10.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.11 Spain
8.3.11.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.3.11.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.3.11.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.3.11.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.3.12 Rest of Europe
8.3.12.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027 (USD Billion)
8.3.12.2 Market Estimates & Forecast Analysis, By Services, 2019-2027 (USD Billion)
8.3.12.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027 (USD Billion)
8.3.12.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4 Asia Pacific
8.4.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.4.2 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.3 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.4 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.6 China
8.4.6.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.6.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.6.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.7 India
8.4.7.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.7.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.7.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.8 Japan
8.4.8.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.8.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.8.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.8.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.9 Indonesia
8.4.9.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.9.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.9.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.10 South Korea
8.4.10.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.10.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.10.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.10 Thailand
8.4.10.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.10.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.10.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.11 Vietnam
8.4.11.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.11.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.11.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.11.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.12 Singapore
8.4.12.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.12.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.12.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.12.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.13 Malaysia
8.4.13.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.4.13.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.4.13.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.4.13.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.4.14 Rest of Asia Pacific
8.4.14.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027 (USD Billion)
8.4.14.2 Market Estimates & Forecast Analysis, By Services, 2019-2027 (USD Billion)
8.4.14.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027 (USD Billion)
8.4.14.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.5 Central & South America
8.5.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.5.2 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.5.3 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.5.4 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.5.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.5.6 Brazil
8.5.6.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.5.6.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.5.6.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.5.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.5.7 Argentina
8.5.7.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.5.7.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.5.7.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.5.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.5.8 Chile
8.5.8.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.5.8.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.5.8.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.5.8.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.5.9 Rest of Central & South America
8.5.9.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.5.9.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.5.9.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.5.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6 Middle East & Africa
8.6.1 Market Estimates & Forecast Analysis, By Country 2019-2027(USD Billion)
8.6.2 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.6.3 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.6.4 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.6.5 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6.6 Saudi Arabia
8.6.6.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.6.6.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.6.6.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.6.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6.7 United Arab Emirates
8.6.7.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.6.7.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.6.7.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.6.7.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6.8 South Africa
8.6.8.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.6.8.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.6.8.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.6.8.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6.9 Israel
8.6.9.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.6.9.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.6.9.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.6.9.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6.10 South Africa
8.6.10.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027(USD Billion)
8.6.10.2 Market Estimates & Forecast Analysis, By Services, 2019-2027(USD Billion)
8.6.10.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027(USD Billion)
8.6.10.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
8.6.11 Rest of Middle East & Africa
8.6.11.1 Market Estimates & Forecast Analysis, By Clinical Phase, 2019-2027 (USD Billion)
8.6.11.2 Market Estimates & Forecast Analysis, By Services, 2019-2027 (USD Billion)
8.6.11.3 Market Estimates & Forecast Analysis, By Therapeutic Use, 2019-2027 (USD Billion)
8.6.11.4 Market Estimates & Forecast Analysis, By End-User, 2019-2027(USD Billion)
Chapter 9 Competitive Analysis
9.1 Key Global Players, Recent Developments & their Impact on the Industry
9.2 Four Quadrant Competitor Positioning Matrix
9.2.1 Key Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Market Challengers
9.3 Vendor Landscape Analysis
9.4 End-User Landscape Analysis
9.5 Company Market Share Analysis, 2021
Chapter 10 Company Profile Analysis
10.1 Catalent, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Strategic Initiatives
10.1.4 Clinical Phase Benchmarking
10.2 Biocair
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Strategic Initiatives
10.2.4 Clinical Phase Benchmarking
10.3 Almac Group
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Strategic Initiatives
10.3.4 Clinical Phase Benchmarking
10.4 Parexel International Corporation
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Strategic Initiatives
10.4.4 Clinical Phase Benchmarking
10.5 Alium Medical Limited
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Strategic Initiatives
10.5.4 Clinical Phase Benchmarking
10.6 Ancillare
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Strategic Initiatives
10.6.4 Clinical Phase Benchmarking
10.7 SIRO Clinpharm Private Limited
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Strategic Initiatives
10.7.4 Clinical Phase Benchmarking
10.8 Sharp
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Strategic Initiatives
10.8.4 Clinical Phase Benchmarking
10.9 Thermo Fisher Scientific Inc.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Strategic Initiatives
10.9.4 Clinical Phase Benchmarking
10.10 LP.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Strategic Initiatives
10.10.4 Clinical Phase Benchmarking
10.11 Other Companies
10.11.1 Company Overview
10.11.2 Financial Analysis
10.11.3 Strategic Initiatives
10.11.4 Clinical Phase Benchmarking
List of Tables
1 Technological Advancements In Clinical Trial Supplies Market
2 Global Clinical Trial Supplies Market: Key Market Drivers
3 Global Clinical Trial Supplies Market: Key Market Challenges
4 Global Clinical Trial Supplies Market: Key Market Opportunities
5 Global Clinical Trial Supplies Market: Key Market Restraints
6 Global Clinical Trial Supplies Market Estimates & Forecast Analysis, 2019-2027 (USD Billion)
7 Global Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
8 Phase 1: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
9 Phase 2 Markets: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
10 Phase 3: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
11 Other phases: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
12 Global Clinical Trial Supplies Market, By Services, 2019-2027 (USD Billion)
13 Manufacturing: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
14 Storage & Distribution: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
15 Supply Chain Management: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
16 Global Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
17 Oncology: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
18 Diabetes: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
19 Therapeutics, and Diagnostic Imaging: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
20 Global Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
21 Pharmaceuticals: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
22 Regional Analysis: Global Clinical Trial Supplies Market, By Region, 2019-2027 (USD Billion)
23 North America: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
24 North America: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
25 North America: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
26 North America: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
27 North America: Clinical Trial Supplies Market, By Country, 2019-2027 (USD Billion)
28 U.S: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
29 U.S: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
30 U.S: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
31 U.S: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
32 Canada: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
33 Canada: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
34 Canada: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
35 Canada: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
36 Mexico: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
37 Mexico: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
38 Mexico: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
39 Mexico: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
40 Europe: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
41 Europe: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
42 Europe: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
43 Europe: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
44 Germany: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
45 Germany: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
46 Germany: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
47 Germany: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
48 UK: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
49 UK: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
50 UK: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
51 UK: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
52 France: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
53 France: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
54 France: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
55 France: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
56 Italy: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
57 Italy: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
58 Italy: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
59 ltaly: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
60 Spain: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
61 Spain: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
62 Spain: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
63 Spain: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
64 Netherlands: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
65 Netherlands: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
66 Netherlands: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
67 Netherlands: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
68 Rest Of Europe: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
69 Rest Of Europe: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
70 Rest Of Europe: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
71 Rest of Europe: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
72 Asia Pacific: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
73 Asia Pacific: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
74 Asia Pacific: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
75 Asia Pacific: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
76 Asia Pacific: Clinical Trial Supplies Market, By Country, 2019-2027 (USD Billion)
77 China: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
78 China: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
79 China: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
80 China: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
81 India: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
82 India: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
83 India: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
84 India: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
85 Japan: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
86 Japan: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
87 Japan: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
88 Japan: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
89 South Korea: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
90 South Korea: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
91 South Korea: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
92 South Korea: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
93 Thailand: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
94 Thailand: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
95 Thailand: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
96 Thailand: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
97 Indonesia: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
98 Indonesia: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
99 Indonesia: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
100 Indonesia: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
101 Malaysia: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
102 Malaysia: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
103 Malaysia: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
104 Malaysia: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
105 Singapore: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
106 Singapore: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
107 Singapore: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
108 Singapore: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
109 Vietnam: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
110 Vietnam: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
111 Vietnam: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
112 Vietnam: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
113 Rest of Asia Pacific: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
114 Rest of Asia Pacific: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
115 Rest of Asia Pacific: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
116 Rest of Asia Pacific: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
117 Middle East & Africa: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
118 Middle East & Africa: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
119 Middle East & Africa: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
120 Middle East & Africa: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
121 Middle East & Africa: Clinical Trial Supplies Market, By Country, 2019-2027 (USD Billion)
122 Saudi Arabia: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
123 Saudi Arabia: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
124 Saudi Arabia: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
125 Saudi Arabia: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
126 UAE: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
127 UAE: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
128 UAE: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
129 UAE: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
130 South Africa: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
131 South Africa: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
132 South Africa: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
133 South Africa: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
134 Israel: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
135 Israel: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
136 Israel: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
137 Israel: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
138 Rest of Middle East & Africa: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
139 Rest of Middle East & Africa: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
140 Rest of Middle East & Africa: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
141 Rest of Middle East & Africa: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
142 Central & South America: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
143 Central & South America: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
144 Central & South America: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
145 Central & South America: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
146 Central & South America: Clinical Trial Supplies Market, By Country, 2019-2027 (USD Billion)
147 Brazil: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
148 Brazil: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
149 Brazil: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
150 Brazil: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
151 Argentina: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
152 Argentina: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
153 Argentina: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
154 Argentina: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
155 Chile: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
156 Chile: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
157 Chile: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
158 Chile: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
159 Rest of Central & South America: Clinical Trial Supplies Market, By Clinical Phase, 2019-2027 (USD Billion)
160 Rest of Central & South America: Clinical Trial Supplies Market, By Service, 2019-2027 (USD Billion)
161 Rest of Central & South America: Clinical Trial Supplies Market, By Therapeutic Use, 2019-2027 (USD Billion)
162 Rest of Central & South America: Clinical Trial Supplies Market, By End-User, 2019-2027 (USD Billion)
163 Catalent, Inc.: Clinical Phases Offered
164 Biocair: Clinical Phases Offered
165 Almac Group: Clinical Phases Offered
166 Parexel International Corporation: Clinical Phases Offered
167 Alium Medical Limited : Clinical Phases Offered
168 Ancillare: Clinical Phases Offered
169 SIRO Clinpharm Private Limited: Clinical Phases Offered
170 Sharp: Clinical Phases Offered
171 Thermo Fisher Scientific Inc.: Clinical Phases Offered
172 LP.: Clinical Phases Offered
173 Analog Devices, Inc: Clinical Phases Offered
174 Other Companies: Clinical Phases Offered
List of Figures
1. Global Clinical Trial Supplies Market Segmentation & Research Scope
2. Primary Research Partners and Local Informers
3. Primary Research Process
4. Primary Research Approaches
5. Primary Research Responses
6. Global Clinical Trial Supplies Market: Penetration & Growth Prospect Mapping
7. Global Clinical Trial Supplies Market: Value Chain Analysis
8. Global Clinical Trial Supplies Market Drivers
9. Global Clinical Trial Supplies Market Restraints
10. Global Clinical Trial Supplies Market Opportunities
11. Global Clinical Trial Supplies Market Challenges
12. Key Clinical Trial Supplies Market Manufacturer Analysis
13. Global Clinical Trial Supplies Market: Porter’s Five Forces Analysis
14. PESTLE Analysis & Impact Analysis
15. Catalent, Inc.: Company Snapshot
16. Catalent, Inc.: Swot Analysis
17. Biocair: Company Snapshot
18. Biocair: Swot Analysis
19. Almac Group: Company Snapshot
20. Almac Group: Swot Analysis
21. Parexel International Corporation: Company Snapshot
22. Parexel International Corporation: Swot Analysis
23. Alium Medical Limited : Company Snapshot
24. Alium Medical Limited : Swot Analysis
25. Ancillare: Company Snapshot
26. Ancillare: Swot Analysis
27. SIRO Clinpharm Private Limited: Company Snapshot
28. SIRO Clinpharm Private Limited: Swot Analysis
29. SHARP: Company Snapshot
30. SHARP: Swot Analysis
31. Thermo Fisher Scientific Inc.: Company Snapshot
32. Thermo Fisher Scientific Inc.: Swot Analysis
33. Enchandia AB Software: Company Snapshot
34. Enchandia AB Software: Swot Analysis
35. LP.: Company Snapshot
36. LP.: Swot Analysis
37. Analog Devices, Inc: Company Snapshot
38. Analog Devices, Inc: Swot Analysis
39. Other Companies: Company Snapshot
40. Other Companies: Swot Analysis
The Global Clinical Trial Supplies Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Clinical Trial Supplies Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
